An open trial of topical urocanic acid for the treatment of stable plaque psoriasis.
Vestey
J P
JP
Norval
M
M
D000279:Administration, Cutaneous; D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000875:Anthralin / Q000008:administration & dosage / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004817:Epidermis / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D009779:Occlusive Dressings; D009824:Ointments; D011565:Psoriasis / Q000188:drug therapy*; D012720:Severity of Illness Index; D013237:Stereoisomerism; D013638:Tars / Q000627:therapeutic use; D014560:Urocanic Acid / Q000008:administration & dosage / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D009824:Ointments; D013638:Tars; D014560:Urocanic Acid; D000875:Anthralin